Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

11 Biotech Stocks With Bullish Short Trends
Seeking Alpha
Wednesday, November 23, 2011 - 11:14am
tags:
Biomarin, BioSpecifics Technologies, Complete Genomics, Incyte, Medivation, Insmed, Momenta, Questcor, Seattle Genetics, Sangamo BioSciences, XenoPort
Don't Get Too Worked Up Over InterMune's Earnings
Motley Fool
Wednesday, November 23, 2011 - 10:42am
tags:
earnings, InterMune
Merck said to hijack German rival's Facebook page
Yahoo/Reuters
Wednesday, November 23, 2011 - 10:39am
tags:
Merck, Merck KGaA, Facebook
Celgene Halts Prostate-Cancer Study for Top-Selling Revlimid
Bloomberg
Wednesday, November 23, 2011 - 9:25am
tags:
prostate cancer, Celgene, Revlimid
Gilead could have had Pharmasset cheap: founder
Reuters
Wednesday, November 23, 2011 - 9:23am
tags:
Pharmasset, Gilead, M&A
Statins safe, even after a decade of use
Reuters
Wednesday, November 23, 2011 - 9:18am
tags:
statins
Merck to Pay $950 Million to Settle Government’s Vioxx Probe
Bloomberg
Tuesday, November 22, 2011 - 3:29pm
tags:
settlements, Merck, Vioxx
Top five ways Big Pharma can address neglected diseases
Forbes
Tuesday, November 22, 2011 - 3:28pm
tags:
Big Pharma, malaria, tropical diseases, tuberculosis
Pfizer plans direct-to-consumer Lipitor sales
Fierce Pharma
Tuesday, November 22, 2011 - 12:06pm
tags:
Pfizer, statins, Lipitor, DTC
Time decay is key to Exelixis strategy
Yahoo/optionMONSTER
Tuesday, November 22, 2011 - 11:58am
tags:
Exelixis, cabozantinib, prostate cancer
Lipid Signaling Could Shake Up Biotech In 2012 With Pending Lpath And Peregrine Trial Data
Seeking Alpha
Tuesday, November 22, 2011 - 11:57am
tags:
Lpath, lipid signaling, Peregrine Pharmaceuticals, Novartis, Pfizer, Biogen Idec
Former Teva CEO Eli Hurvitz dies in Israel
Google/AP
Tuesday, November 22, 2011 - 11:05am
tags:
Teva Pharmaceuticals, Eli Hurvitz
Ireland Faces $26B Decline in Drug Exports
Bloomberg
Tuesday, November 22, 2011 - 11:02am
tags:
patents, Ireland, Pfizer, Lipitor
Bet On The Biotech Sector: The War On Neurodegenerative Disease
Seeking Alpha
Tuesday, November 22, 2011 - 10:58am
tags:
neurodegenerative disease, Sanofi, Valeant Pharmaceuticals, Novartis, Zelapar, Comtan, Parkinson's Disease
Newt Gingrich Denies Lobbying for Drug Makers
Medical Daily
Tuesday, November 22, 2011 - 10:55am
tags:
lobbying, Newt Gingrich
Deloitte: The price of R&D success soars as investment returns shrivel
Fierce Biotech
Tuesday, November 22, 2011 - 10:47am
tags:
R&D
Celldex shares rally (briefly) on positive PhII brain cancer data
Fierce Biotech
Tuesday, November 22, 2011 - 10:46am
tags:
brain cancer, Celldex, CDX-110, vaccines
2-Star Stocks Poised to Plunge: AMAG Pharmaceuticals?
Motley Fool
Tuesday, November 22, 2011 - 10:39am
tags:
Amag Pharmaceuticals
Novartis Execs, Cover-Ups And Jawbone Damage
Pharmalot
Tuesday, November 22, 2011 - 9:41am
tags:
Novartis, Zometa, Aredia
Pharmasset Shows Inhibitex-to-Achillion Drugmakers Up for Grabs: Real M&A
Bloomberg
Tuesday, November 22, 2011 - 9:39am
tags:
Inhibitex, Achillion, Pharmasset, Gilead, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.